BioNTech vs Enterome
BioNTech vs Enterome, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and Enterome on 60/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 60/100
- agent readiness: 40/100 against 21/100
- domain rating: 74/100 against 46/100
- headcount: 5,128 against 33
- funding raised: $975M against $124M
- LinkedIn following: 295,812 against 16,846
Enterome
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BioNTech | Enterome |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Drug Discovery, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Software | hardware | services | marketplace | platform |
| Founded | 2008 | 2012 |
| Headquarters | Mainz, Germany | Paris, France |
| Status | Active | Active |
Size, funding and growth
| Measure | BioNTech | Enterome |
|---|---|---|
| Employees | 5,128 | 33 |
| Total funding | $975M | $124M |
| Latest round | Loan | Later Stage VC |
| LinkedIn followers | 295,812 | 16,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | Enterome |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 60/100 |
| Traction | 60/100 | 55/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 35/100 | 34/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | Enterome |
|---|---|---|
| Hosting | Azure | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Bootstrap |
| Analytics | Google Tag Manager | Google Analytics 4, Segment |
BioNTech vs Enterome: common questions
Which is better, BioNTech or Enterome?
On our 0-100 score BioNTech rates higher (66/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do BioNTech and Enterome compare on the numbers?
BioNTech leads on our overall score (66/100 against 60/100), agent readiness (40/100 against 21/100), domain rating (74/100 against 46/100), headcount (5,128 against 33), funding raised ($975M against $124M), LinkedIn following (295,812 against 16,846).
Read the full BioNTech review and pricing or the Enterome review and pricing. You can also browse other BioNTech alternatives we track.